STAT+: What’s the deal with Isomorphic Labs?

T1Covered by 1 source · first reported by STAT News (health-tech) at 21 Oct, 17:49 UTC

In this edition of STAT's AI Prognosis: What does Isomorphic Labs' high valuation say about AI's role in drug development, and the debate around AI and cost of care.

businessscience

Sources

• T1STAT+: What’s the deal with Isomorphic Labs?STAT News (health-tech)21 Oct, 17:49